2.1. Study Population
From January 2009 to April 2020, 84 consecutive patients with SHD
underwent RF ablation (116 procedures) for drug-resistant VT in our
hospital. Patients who underwent multiple procedures were evaluated
during the last procedure.
VT non-inducibility was achieved in 20 patients but it was not achieved
in 64. To evaluate the validity of “VT non-inducibility” as an
endpoint of RF ablation, 64 patients in whom VT non-inducibility was not
achieved were studied. The study was approved by the ethics committee of
Kobe University Hospital, and all patients gave their written informed
consent.